These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 18493654)
1. Visualizing the spatial distribution of secondary metabolites produced by marine cyanobacteria and sponges via MALDI-TOF imaging. Esquenazi E; Coates C; Simmons L; Gonzalez D; Gerwick WH; Dorrestein PC Mol Biosyst; 2008 Jun; 4(6):562-70. PubMed ID: 18493654 [TBL] [Abstract][Full Text] [Related]
2. Biomedicinals from the phytosymbionts of marine invertebrates: a molecular approach. Dunlap WC; Battershill CN; Liptrot CH; Cobb RE; Bourne DG; Jaspars M; Long PF; Newman DJ Methods; 2007 Aug; 42(4):358-76. PubMed ID: 17560324 [TBL] [Abstract][Full Text] [Related]
3. Dysideaprolines A-F and barbaleucamides A-B, novel polychlorinated compounds from a Dysidea species. Harrigan GG; Goetz GH; Luesch H; Yang S; Likos J J Nat Prod; 2001 Sep; 64(9):1133-8. PubMed ID: 11575943 [TBL] [Abstract][Full Text] [Related]
4. Transcriptional analysis of the jamaicamide gene cluster from the marine cyanobacterium Lyngbya majuscula and identification of possible regulatory proteins. Jones AC; Gerwick L; Gonzalez D; Dorrestein PC; Gerwick WH BMC Microbiol; 2009 Dec; 9():247. PubMed ID: 19951434 [TBL] [Abstract][Full Text] [Related]
5. Genomic insights into the physiology and ecology of the marine filamentous cyanobacterium Lyngbya majuscula. Jones AC; Monroe EA; Podell S; Hess WR; Klages S; Esquenazi E; Niessen S; Hoover H; Rothmann M; Lasken RS; Yates JR; Reinhardt R; Kube M; Burkart MD; Allen EE; Dorrestein PC; Gerwick WH; Gerwick L Proc Natl Acad Sci U S A; 2011 May; 108(21):8815-20. PubMed ID: 21555588 [TBL] [Abstract][Full Text] [Related]
6. Morphological, chemical, and genetic diversity of tropical marine cyanobacteria Lyngbya spp. and Symploca spp. (Oscillatoriales). Thacker RW; Paul VJ Appl Environ Microbiol; 2004 Jun; 70(6):3305-12. PubMed ID: 15184125 [TBL] [Abstract][Full Text] [Related]
7. Palmyramide A, a cyclic depsipeptide from a Palmyra Atoll collection of the marine cyanobacterium Lyngbya majuscula. Taniguchi M; Nunnery JK; Engene N; Esquenazi E; Byrum T; Dorrestein PC; Gerwick WH J Nat Prod; 2010 Mar; 73(3):393-8. PubMed ID: 19839606 [TBL] [Abstract][Full Text] [Related]
8. Mass Spectrometry-Based Integration and Expansion of the Chemical Diversity Harbored Within a Marine Sponge. Cantrell TP; Freeman CJ; Paul VJ; Agarwal V; Garg N J Am Soc Mass Spectrom; 2019 Aug; 30(8):1373-1384. PubMed ID: 31093948 [TBL] [Abstract][Full Text] [Related]
9. Anti-Infective Secondary Metabolites of the Marine Cyanobacterium Youssef DTA; Mufti SJ; Badiab AA; Shaala LA Mar Drugs; 2022 Dec; 20(12):. PubMed ID: 36547915 [TBL] [Abstract][Full Text] [Related]
11. High resolution spatial mapping of brominated pyrrole-2-aminoimidazole alkaloids distributions in the marine sponge Stylissa flabellata via MALDI-mass spectrometry imaging. Yarnold JE; Hamilton BR; Welsh DT; Pool GF; Venter DJ; Carroll AR Mol Biosyst; 2012 Sep; 8(9):2249-59. PubMed ID: 22777271 [TBL] [Abstract][Full Text] [Related]
12. Culture of the marine cyanobacterium, Lyngbya majuscula (Oscillatoriaceae), for bioprocess intensified production of cyclic and linear lipopeptides. Burja AM; Abou-Mansour E; Banaigs B; Payri C; Burgess JG; Wright PC J Microbiol Methods; 2002 Feb; 48(2-3):207-19. PubMed ID: 11777570 [TBL] [Abstract][Full Text] [Related]
13. Ion mobility mass spectrometry enables the efficient detection and identification of halogenated natural products from cyanobacteria with minimal sample preparation. Esquenazi E; Daly M; Bahrainwala T; Gerwick WH; Dorrestein PC Bioorg Med Chem; 2011 Nov; 19(22):6639-44. PubMed ID: 21784647 [TBL] [Abstract][Full Text] [Related]
14. Underestimated biodiversity as a major explanation for the perceived rich secondary metabolite capacity of the cyanobacterial genus Lyngbya. Engene N; Choi H; Esquenazi E; Rottacker EC; Ellisman MH; Dorrestein PC; Gerwick WH Environ Microbiol; 2011 Jun; 13(6):1601-10. PubMed ID: 21477107 [TBL] [Abstract][Full Text] [Related]
15. Biopotentials of marine sponges from China oceans: past and future. Zhang W; Xue S; Zhao Q; Zhang X; Li J; Jin M; Yu X; Yuan Q Biomol Eng; 2003 Jul; 20(4-6):413-9. PubMed ID: 12919827 [TBL] [Abstract][Full Text] [Related]
16. Speciation and biosynthetic variation in four dictyoceratid sponges and their cyanobacterial symbiont, Oscillatoria spongeliae. Ridley CP; Bergquist PR; Harper MK; Faulkner DJ; Hooper JN; Haygood MG Chem Biol; 2005 Mar; 12(3):397-406. PubMed ID: 15797223 [TBL] [Abstract][Full Text] [Related]
17. Secondary Metabolites from the Marine Sponge Genus Phyllospongia. Zhang H; Dong M; Wang H; Crews P Mar Drugs; 2017 Jan; 15(1):. PubMed ID: 28067826 [No Abstract] [Full Text] [Related]
19. Marine sponge derived natural products between 2001 and 2010: trends and opportunities for discovery of bioactives. Mehbub MF; Lei J; Franco C; Zhang W Mar Drugs; 2014 Aug; 12(8):4539-77. PubMed ID: 25196730 [TBL] [Abstract][Full Text] [Related]
20. The guineamides, novel cyclic depsipeptides from a Papua New Guinea collection of the marine cyanobacterium Lyngbya majuscula. Tan LT; Sitachitta N; Gerwick WH J Nat Prod; 2003 Jun; 66(6):764-71. PubMed ID: 12828459 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]